Medifast (MED) Tops Q3 EPS by 11c

Medifast (NYSE: MED) reported Q3 EPS of $0.47, $0.11 better than the analyst estimate of $0.36. Revenue for the quarter came in at $74 million versus the consensus estimate of $76.1 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15